Journal article
Erratum: Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: A five month multicentre Canadian study (Canadian Respiratory Journal (2003) vol. 10 (8) (427-434))
Abstract
Background: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund. Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level. Objective: To compare adjustable and fixed maintenance dosing regimens of budesonide/formoterol in asthma. Methods: This was as open-label, randomized, parallel-group, multicentre, Canadian study of asthma patients …
Authors
FitzGerland JM; Sears MR; Boulet LP; Becker AB
Journal
Canadian Respiratory Journal, Vol. 11, No. 1,
Publication Date
January 1, 2004
ISSN
1198-2241